Psychedelia.dk

Jeg faldt lige over den her og tænkte jeg ville dele den herinde Den er publiceret i Journal of Psychopharmacology i juli i år.

http://jop.sagepub.com/content/early/20 ... 78371.long

"Clinical response was defined as >30% reduction from baseline
in CAPS total severity score. In Stage 1, the clinical
response was 83.3% (10/12) in the MDMA group versus
25% (2/8) in the placebo group. Likewise, 10 of the
MDMA group no longer met DSM-IV criteria for PTSD
compared with two of the placebo group. In Stage 2, the
clinical response rate was 100% in the seven subjects, six of
whom had failed to respond to placebo and one of whom had
relapsed after an initial placebo response. An unplanned
observation was that all three subjects who reported being
unable to work due to PTSD were able to return to work."

Jep, det er super-interessant. Det er også blevet nævnt på P1 et par gange her på det sidste.
Vi må håbe at der bliver foretaget flere trials af den slags, men med en noget større patientgruppe.

Det er virkelig et godt initiativ, ikke mindst set fra de lidendes synsvinkel. De fleste af os herinde der har prøvet MDMA, kan nok nikke genkendende til den terapeutiske/mentalt helende effekt MDMA har på én, både under og efter oplevelsen.
At dette måske har mulighed for at blive bredt ud til kronisk indlagte/kronisk medicinerede patienter, er da vildt livsbekræftende

_________________
Once you get locked into a serious drug collection, the tendency is to push it as hard as you can.
Gør dig selv en tjeneste, og lad være med at starte en samling.